OralParenteralTopicalDosed ingredientTherapeutic flag Cosmetic cross-reference

Aminophylline

CAS 317-34-0

Aminophylline (CAS 317-34-0) is a Phase 4 pharmaceutical compound with 5 bioactivity targets and 83 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
5
SOURCE DrugCentral
Adverse signals
83
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Aminophylline
CAS Number
317-34-0
UNII
27Y3KJK423
InChIKey
FQPFAHBPWDRTLU-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1370561
Molecule Type
Protein
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
dosed ingredientoralparenteraltherapeutic flagtopical
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1370561 | Protein
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 5 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- IC50 31542.078461538462 nM 13 -
- Potency 12965.828571428572 nM 6 -
- AC50 31622.78 nM 1 -
- EC50 50 nM 1 -
- Kd 47.86 nM 1 -
SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
AMINOPHYLLINE 689 SU MTHSPL
aminophylline 689 IN RXNORM
SOURCE SIDER 80 side-effect rows

Side Effects

SIDER side-effect terms mapped to the drug or same-CAS compound identity.

Side EffectDrug Name MedDRA TypeConcept ID
Abdominal cramps aminophylline LLT C0000729
Abdominal pain aminophylline PT C0000737
Abdominal pain aminophylline LLT C0000737
Abdominal pain aminophylline PT C0000737
Abdominal pain upper aminophylline PT C0232492
Acute overdose aminophylline LLT C1963951
Agitation aminophylline LLT C0085631
Agitation aminophylline PT C0085631
Agitation aminophylline PT C0085631
Albuminuria aminophylline LLT C0001925
Albuminuria aminophylline PT C0001925
Anorexia aminophylline LLT C0003123
Anxiety aminophylline LLT C0003467
Anxiety aminophylline PT C0003467
Arrhythmia aminophylline LLT C0003811
Arrhythmia aminophylline PT C0003811
Atrial fibrillation aminophylline LLT C0004238
Atrial fibrillation aminophylline PT C0004238
Atrial tachycardia aminophylline PT C0546959
Body temperature increased aminophylline LLT C0015967
Body temperature increased aminophylline PT C0015967
Bronchial hyperreactivity aminophylline PT C0085129
Cardiac flutter aminophylline LLT C0016385
Cardiac flutter aminophylline PT C0016385
Chronic obstructive pulmonary disease aminophylline LLT C0024117
Chronic obstructive pulmonary disease aminophylline PT C0024117
Convulsion aminophylline LLT C0036572
Convulsion aminophylline PT C0036572
Decreased appetite aminophylline PT C0232462
Dermatitis aminophylline LLT C0011603
Dermatitis aminophylline PT C0011603
Dermatitis aminophylline PT C0011603
Dermatitis contact aminophylline LLT C0011616
Dermatitis contact aminophylline PT C0011616
Dermatitis exfoliative aminophylline LLT C0011606
Dermatitis exfoliative aminophylline PT C0011606
Diarrhoea aminophylline LLT C0011991
Diarrhoea aminophylline PT C0011991
Disorientation aminophylline LLT C0233407
Disorientation aminophylline PT C0233407
Diuresis aminophylline LLT C0012797
Dizziness aminophylline LLT C0012833
Dizziness aminophylline PT C0012833
Dizziness aminophylline PT C0012833
Dyspepsia aminophylline PT C0013395
Epigastric pain aminophylline LLT C0232493
Excitement aminophylline LLT C0233571
Extrasystoles aminophylline LLT C0340464
Extrasystoles aminophylline PT C0340464
Flushing aminophylline LLT C0016382
Flushing aminophylline PT C0016382
Gastrointestinal pain aminophylline PT C0687713
Haematemesis aminophylline LLT C0018926
Haematemesis aminophylline PT C0018926
Haemodynamic instability aminophylline LLT C0948268
Haemodynamic instability aminophylline PT C0948268
Headache aminophylline LLT C0018681
Headache aminophylline PT C0018681
Heartburn aminophylline LLT C0018834
Hyperglycaemia aminophylline LLT C0020456
Hyperglycaemia aminophylline PT C0020456
Hypersensitivity aminophylline LLT C0020517
Hypersensitivity aminophylline PT C0020517
Hypokalaemia aminophylline LLT C0020621
Hypokalaemia aminophylline PT C0020621
Hypotension aminophylline LLT C0020649
Hypotension aminophylline PT C0020649
Insomnia aminophylline LLT C0917801
Insomnia aminophylline PT C0917801
Intoxication aminophylline LLT C0728899
Irritability aminophylline LLT C0022107
Irritability aminophylline PT C0022107
Lightheadedness aminophylline LLT C0220870
Multifocal atrial tachycardia aminophylline LLT C0221158
Nausea aminophylline LLT C0027497
Nausea aminophylline PT C0027497
Nervousness aminophylline LLT C0027769
Nervousness aminophylline PT C0027769
Overdose aminophylline PT C0029944
Palpitations aminophylline LLT C0030252
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Aminophylline used for in pharmaceutical contexts?

Aminophylline (CAS 317-34-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Aminophylline?

Aminophylline has 83 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Alopecia, Amyloid arthropathy, Anaemia, Arthropathy. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Aminophylline also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Aminophylline with EU status "prohibited".

What clinical phase is Aminophylline in?

Aminophylline is rendered with ChEMBL max phase 4 (approved).